Faecal calprotectin: current usage and perceived beneficial effects of third‐party funding on rates of colonoscopy by Australian gastroenterologists
暂无分享,去创建一个
J. Andrews | S. Connor | M. Sparrow | I. Fok | P. Gibson | O. Elnawsra
[1] G. Holtmann,et al. Clinical triage for colonoscopy is useful in young women , 2015, Internal medicine journal.
[2] C. Lees,et al. Clinical Utility And Diagnostic Accuracy of Faecal Calprotectin For IBD At First Presentation To Gastroenterology Services In Adults Aged 16–50 Years , 2014, Journal of Crohn's & colitis.
[3] T. Price,et al. P123 The use of faecal calprotectin in IBD and reducing unnecessary colonoscopy , 2014 .
[4] C. Clar,et al. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. , 2013, Health technology assessment.
[5] James Church,et al. Complications of colonoscopy. , 2013, Gastroenterology clinics of North America.
[6] A. Larsson,et al. Ruling out IBD: estimation of the possible economic effects of pre-endoscopic screening with F-calprotectin. , 2012, Clinical biochemistry.
[7] I. Dale,et al. Release and Quantitation of a Leucocyte Derived Protein (L1) , 2009 .
[8] L. Denson,et al. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease , 2006, Inflammatory bowel diseases.
[9] John A. Evans,et al. Complications of Colonoscopy , 2013, Annals of Internal Medicine.
[10] H. Verspaget,et al. Value of indium-111 tropolonate autologous granulocyte scintigraphy in the assessment of inflammatory bowel disease. , 1990, Scandinavian journal of gastroenterology. Supplement.